AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Deferasirox in Nigeria
3 products registered with NAFDAC — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Oleptiss 360 mg Film-coated Tablet** Tablet | A4-100405 | Novartis Nigeria Limited | active | 24 May 2028 |
| Oleptiss 90 mg Film-coated Tablet** Tablet | A4-100404 | Novartis Nigeria Limited | active | 24 May 2028 |
| Oleptiss 180 mg Film-coated Tablet** Tablet | A4-100403 | Novartis Nigeria Limited | active | 24 May 2028 |
Deferasirox — NAFDAC Registration Details
NAFDAC (Nigeria) has 3 registered products containing Deferasirox, of which 3 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Deferasirox registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.